Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States

Nina N Sanford; David J Sher; Chul Ahn; Ayal A Aizer; Brandon A Mahal

doi:10.1001/jamaoncol.2019.0349

Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States

JAMA Oncol. 2019 May 1;5(5):735-737. doi: 10.1001/jamaoncol.2019.0349.

Authors

Nina N Sanford¹, David J Sher¹, Chul Ahn^{2

3}, Ayal A Aizer⁴, Brandon A Mahal⁵

Affiliations

¹ Department of Radiation Oncology, University of Texas Southwestern, Dallas.
² Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas.
³ Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas.
⁴ Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
⁵ Dana-Farber Cancer Institute McGraw/Patterson Center for Population Sciences, Boston, Massachusetts.

Abstract

This cross-sectional study analyzes the proportion of patients with cancer and cancer survivors who use complementary and alternative medicine (CAM) without disclosing this information to their physicians.

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Cancer Survivors / psychology*
Cancer Survivors / statistics & numerical data*
Complementary Therapies / psychology*
Complementary Therapies / statistics & numerical data*
Disclosure*
Female
Humans
Male
Middle Aged
Neoplasms / psychology*
Neoplasms / therapy*
Patient Compliance
Physician-Patient Relations*
United States
Young Adult